1. P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial. (30th January 2023) Authors: Van Linschoten, R; Jansen, F; Pauwels, R; Smits, L; Atsma, F; Kievit, W; de Jong, D; de Vries, A; Boekema, P; West, R; Bodelier, A; Gisbertz, I; Wolfhagen, F; Romkens, T; Lutgens, M; van Bodegraven, A; Oldenburg, B; Pierik, M; Russel, M; de Boer, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗